1. Diacron reactive oxygen metabolites and biological antioxidant potential tests for patients with age-related macular degeneration.
- Author
-
Matsuura T, Kaneko H, Takayama K, Shibata R, Kataoka K, Ito S, Tsunekawa T, Shimizu H, Suzumura A, Namba R, Ito Y, Murohara T, and Terasaki H
- Subjects
- Aged, Aged, 80 and over, Choroidal Neovascularization diagnosis, Female, Fluorescein Angiography, Humans, Male, Middle Aged, Visual Acuity physiology, Wet Macular Degeneration diagnosis, Antioxidants metabolism, Biomarkers blood, Choroidal Neovascularization blood, Oxidative Stress, Reactive Oxygen Species blood, Wet Macular Degeneration blood
- Abstract
Background: Previously, we showed that serum malondialdehyde (MDA) was significantly higher in patients with neovascular age-related macular degeneration (nAMD) than in those without AMD. The Diacron reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) tests are known markers of oxidative stress. The aim of this study was to use d-ROMs and BAP tests to evaluate changes in systemic oxidative stress in patients with nAMD., Methods: Blood serum samples were collected from 34 patients with nAMD (mean age: 76.5 ± 7.7 years; 22 men) and 20 control subjects (mean age: 62.9 ± 14.0 years; 10 men), and d-ROMs and BAP tests were examined., Results: In men, the mean level of d-ROMs for the nAMD patients was significantly higher than that for the controls (312.0 ± 52.4 vs. 275.1 ± 45.5 U.CARR, respectively; P < .05). There was a significant correlation between d-ROM level and CNV lesion area in the male nAMD group (r = .42, P = .05). There were no significant differences in mean BAP test results between the nAMD patients and controls for either sex (men: 2241 ± 549 vs. 2136 ± 246 μmol/L; women: 2263 ± 292 vs. 2335 ± 161 μmol/L)., Conclusion: The d-ROMs test may provide a useful indicator of nAMD in men but not in women.
- Published
- 2020
- Full Text
- View/download PDF